These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 10535444

  • 21. Differential roles of insulin receptor substrates in brown adipocyte differentiation.
    Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR.
    Mol Cell Biol; 2004 Mar; 24(5):1918-29. PubMed ID: 14966273
    [Abstract] [Full Text] [Related]

  • 22. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
    Adochio R, Leitner JW, Hedlund R, Draznin B.
    Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
    [Abstract] [Full Text] [Related]

  • 23. Bi-directional regulation of brown fat adipogenesis by the insulin receptor.
    Entingh AJ, Taniguchi CM, Kahn CR.
    J Biol Chem; 2003 Aug 29; 278(35):33377-83. PubMed ID: 12807888
    [Abstract] [Full Text] [Related]

  • 24. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
    Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM.
    J Clin Invest; 2001 May 29; 107(9):1193-202. PubMed ID: 11342583
    [Abstract] [Full Text] [Related]

  • 25. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes.
    Takano A, Haruta T, Iwata M, Usui I, Uno T, Kawahara J, Ueno E, Sasaoka T, Kobayashi M.
    Diabetes; 2001 Aug 29; 50(8):1891-900. PubMed ID: 11473053
    [Abstract] [Full Text] [Related]

  • 26. beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes.
    Klein J, Fasshauer M, Ito M, Lowell BB, Benito M, Kahn CR.
    J Biol Chem; 1999 Dec 03; 274(49):34795-802. PubMed ID: 10574950
    [Abstract] [Full Text] [Related]

  • 27. Phosphatidylinositol 3-kinase is a requirement for insulin-like growth factor I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes.
    Valverde AM, Lorenzo M, Navarro P, Benito M.
    Mol Endocrinol; 1997 May 03; 11(5):595-607. PubMed ID: 9139803
    [Abstract] [Full Text] [Related]

  • 28. Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.
    Frick W, Bauer A, Bauer J, Wied S, Müller G.
    Biochem J; 1998 Nov 15; 336 ( Pt 1)(Pt 1):163-81. PubMed ID: 9806898
    [Abstract] [Full Text] [Related]

  • 29. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.
    Egawa K, Nakashima N, Sharma PM, Maegawa H, Nagai Y, Kashiwagi A, Kikkawa R, Olefsky JM.
    Endocrinology; 2000 Jun 15; 141(6):1930-5. PubMed ID: 10830273
    [Abstract] [Full Text] [Related]

  • 30. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
    Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T.
    Mol Cell Biol; 1996 Jun 15; 16(6):3074-84. PubMed ID: 8649419
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes.
    Valverde AM, Mur C, Brownlee M, Benito M.
    Mol Biol Cell; 2004 Nov 15; 15(11):5101-17. PubMed ID: 15356271
    [Abstract] [Full Text] [Related]

  • 32. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice.
    Howlett KF, Sakamoto K, Hirshman MF, Aschenbach WG, Dow M, White MF, Goodyear LJ.
    Diabetes; 2002 Feb 15; 51(2):479-83. PubMed ID: 11812758
    [Abstract] [Full Text] [Related]

  • 33. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action.
    Deng Y, Bhattacharya S, Swamy OR, Tandon R, Wang Y, Janda R, Riedel H.
    J Biol Chem; 2003 Oct 10; 278(41):39311-22. PubMed ID: 12783867
    [Abstract] [Full Text] [Related]

  • 34. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
    Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM, Kobayashi M.
    Mol Endocrinol; 2000 Jun 10; 14(6):783-94. PubMed ID: 10847581
    [Abstract] [Full Text] [Related]

  • 35. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
    Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Fujishiro M, Kikuchi M, Oka Y, Asano T.
    Diabetes; 2000 Oct 10; 49(10):1700-8. PubMed ID: 11016454
    [Abstract] [Full Text] [Related]

  • 36. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation.
    Miki H, Yamauchi T, Suzuki R, Komeda K, Tsuchida A, Kubota N, Terauchi Y, Kamon J, Kaburagi Y, Matsui J, Akanuma Y, Nagai R, Kimura S, Tobe K, Kadowaki T.
    Mol Cell Biol; 2001 Apr 10; 21(7):2521-32. PubMed ID: 11259600
    [Abstract] [Full Text] [Related]

  • 37. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
    Brüning JC, Winnay J, Cheatham B, Kahn CR.
    Mol Cell Biol; 1997 Mar 10; 17(3):1513-21. PubMed ID: 9032279
    [Abstract] [Full Text] [Related]

  • 38. Possibility of distinct insulin-signaling pathways beyond phosphatidylinositol 3-kinase-mediating glucose transport and lipogenesis.
    Stevenson RW, Kreutter DK, Andrews KM, Genereux PE, Gibbs EM.
    Diabetes; 1998 Feb 10; 47(2):179-85. PubMed ID: 9519710
    [Abstract] [Full Text] [Related]

  • 39. Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts.
    Yamamoto H, Kurebayashi S, Hirose T, Kouhara H, Kasayama S.
    J Cell Sci; 2002 Sep 15; 115(Pt 18):3601-7. PubMed ID: 12186946
    [Abstract] [Full Text] [Related]

  • 40. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.
    Zierath JR, Livingston JN, Thörne A, Bolinder J, Reynisdottir S, Lönnqvist F, Arner P.
    Diabetologia; 1998 Nov 15; 41(11):1343-54. PubMed ID: 9833943
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.